4UIT
BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-2-(4- methanesulfonylpiperazine-1-carbonyl)-5-methyl-4H,5H-thieno-3,2-c- pyridin-4-one
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | DIAMOND BEAMLINE I02 |
| Synchrotron site | Diamond |
| Beamline | I02 |
| Temperature [K] | 100 |
| Collection date | 2012-09-19 |
| Spacegroup name | P 1 |
| Unit cell lengths | 24.700, 34.110, 39.680 |
| Unit cell angles | 70.26, 73.80, 74.24 |
Refinement procedure
| Resolution | 36.540 - 1.300 |
| R-factor | 0.15331 |
| Rwork | 0.152 |
| R-free | 0.17300 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | NONE |
| RMSD bond length | 0.007 |
| RMSD bond angle | 1.122 |
| Data scaling software | SCALA |
| Refinement software | REFMAC (5.6.0117) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 36.540 | 1.370 |
| High resolution limit [Å] | 1.300 | 1.300 |
| Rmerge | 0.030 | 0.050 |
| Number of reflections | 23127 | |
| <I/σ(I)> | 19.4 | 12.7 |
| Completeness [%] | 81.9 | 51.8 |
| Redundancy | 1.9 | 1.9 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | 293 | 0.2M ZNAC, 20% PEG3350 20C |






